BIO CEO & Investor Conference

Now in its 25th year, the BIO CEO & Investor Conference fuels the biotech industry as a premier event for C-Suite leaders and the investor and banking communities, focused on established and emerging publicly traded and select private biotech companies.

Across four days, participate in one of the largest investor conferences where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry through partnering, company presentations, and educational sessions on therapeutic advancements, market outlook, and policy priorities.